comparemela.com

Latest Breaking News On - Xeris pharmaceuticals inc - Page 5 : comparemela.com

Xeris Biopharma (NASDAQ:XERS) Upgraded at Zacks Investment Research

Xeris Biopharma (NASDAQ:XERS – Get Rating) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research note issued to investors on Thursday, Zacks.com reports. According to Zacks, “Xeris Biopharma Holdings is a biopharmaceutical company. It involved in developing and commercializing therapies for patient in endocrinology, neurology and gastroenterology. […]

50,169 Shares in Xeris Pharmaceuticals, Inc (NASDAQ:XERS) Acquired by Ieq Capital LLC

Ieq Capital LLC acquired a new position in Xeris Pharmaceuticals, Inc. (NASDAQ:XERS – Get Rating) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund acquired 50,169 shares of the company’s stock, valued at approximately $147,000. Ieq Capital LLC owned about 0.08% of Xeris Pharmaceuticals as […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.